Premarket approval and federal preemption of product liability claims in the wake of Medtronic, Inc. v. Lohr.
作者信息
Jarcho D G
机构信息
McKenna & Cuneo, L.L.P., Washington, D.C., USA.
出版信息
Food Drug Law J. 1996;51(4):613-8.
PMID:11797730
Abstract
摘要
相似文献
1
Premarket approval and federal preemption of product liability claims in the wake of Medtronic, Inc. v. Lohr.
Food Drug Law J. 1996;51(4):613-8.
2
Medical device preemption after Medtronic, Inc. v. Lohr.
Food Drug Law J. 1996;51(4):619-29.
3
Federal preemption of common law tort awards by the Federal Food, Drug, and Cosmetic Act.
Food Drug Law J. 1996;51(4):509-611.
4
Federal pre-emption under the Food, Drug & Cosmetic Act from Medtronic, Inc. v. Lohr; Pliva. Inc. v. Mensing.
Health Care Law Mon. 2011 Sep;2011(9):2-8.
5
Guide to preemption of state-law claims against Class III PMA medical devices.
Food Drug Law J. 2010;65(1):113-39, ii-iii.
6
Life after Riegel: a fresh look at medical device preemption one year after Riegel v. Medtronic, Inc.
Food Drug Law J. 2009;64(2):291-311.
7
License to maim: federal pre-emption and the Medical Device Amendments of 1976.
Health Matrix Clevel. 1996 Summer;6(2):349-89.
8
9
Express preemption and premarket approval under the Medical Device Amendments.
Food Drug Law J. 2004;59(2):245-64.
10
Post-decision diagnosis: medical device preemption alive and mostly well after Medtronic, Inc. v. Lohr.
Ann Health Law. 1997;6:185-208.
Zotero 插件